Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1885815

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1885815

Single-Cell Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Single-Cell Protein Hydrolysates Market was valued at USD 288.4 million in 2024 and is estimated to grow at a CAGR of 9.5% to reach USD 721 million by 2034.

Single-Cell Protein Hydrolysates Market - IMG1

Single-cell protein (SCP) hydrolysates are becoming a crucial component of the sustainable protein economy, supported by their strong digestibility, amino acid availability, and functional attributes derived from microbial sources such as bacteria, yeast, fungi, and microalgae. Their production is associated with a low environmental footprint, often relying on waste streams or gas-based feedstocks, which enhances their appeal across animal nutrition, human food applications, and nutraceuticals. As global protein requirements increase and environmental pressures intensify, SCP hydrolysates are gaining prominence in aquaculture diets, clinical nutrition, and circular bioeconomy strategies. Their alignment with circular systems, especially using industrial off-gases, organic residues, and biomass-derived substrates, helps address land constraints, emission reduction efforts, and food security priorities. These factors are moving SCP hydrolysates from emerging technologies into widely adopted commercial solutions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$288.4 Million
Forecast Value$721 Million
CAGR9.5%

The bacterial SCP hydrolysates segment accounted for 34% in 2024 and is expected to grow at a CAGR of 8.9% by 2034. Hydrolysates produced from bacterial and yeast platforms continue to expand due to rapid biomass generation, strong scalability, and compatibility with gas-based substrates. They are used to enhance gut performance, while yeast-derived hydrolysates, particularly from Saccharomyces species, are becoming more common in pet food and flavor-enhancing applications.

The animal nutrition segment held a 45.4% share in 2024 and is projected to grow at a CAGR of 9.3% through 2034. Growth is led by aquaculture, driven by the stability and digestibility of SCP ingredients, offering a sustainable alternative to conventional marine-based proteins. Providers of microbial proteins are customizing solutions for various species, and manufacturers in the pet food sector are incorporating yeast and bacterial hydrolysates to improve palatability and digestive health. Livestock operations are also adopting SCP hydrolysates to lower feed expenses and reduce dependency on traditional additives.

U.S. Single-Cell Protein Hydrolysates Market reached USD 70.3 million in 2024 and is anticipated to register a CAGR of 9.5% from 2025 to 2034. With multiple innovators expanding SCP hydrolysate production using natural gas and industrial co-products, the United States remains a key driver of scale-up and technological advancement across feed and nutrition applications.

Major companies participating in the Global Single-Cell Protein Hydrolysates Market include Calysta, Unibio, Solar Foods, KnipBio, Quorn Foods, Arbiom, Corbion, DSM-Firmenich, Novozymes (now part of Novonesis), Angel Yeast, Lesaffre, Alltech, Nutreco, and AlgaeCytes. Companies competing in this market are strengthening their positions through large-scale fermentation expansion, cost-optimized bioprocessing, and advanced strain engineering to boost protein yields and enhance nutrient profiles. Many firms are forming supply partnerships with feed manufacturers and food companies to secure long-term contracts while tailoring hydrolysate compositions for species-specific nutritional needs. Sustainability commitments, including the use of waste-derived and gas-fed feedstocks, are helping companies stand out as environmentally aligned suppliers. Product diversification, regulatory compliance strategies, and investments in high-value applications such as clinical nutrition and functional formulations are further supporting stronger global market footholds.

Product Code: 15313

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Source / Organism Type
    • 2.2.3 Production Substrate / Feedstock
    • 2.2.4 Application
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for sustainable proteins
      • 3.2.1.2 Expansion in aquafeed applications
      • 3.2.1.3 Circular production using waste biomass
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Complex downstream processing costs
      • 3.2.2.2 Regulatory approvals for novel ingredients
    • 3.2.3 Market opportunities
      • 3.2.3.1 CO2 fermentation and power-to-protein tech
      • 3.2.3.2 Growth in sports and clinical nutrition
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By Product type
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Source / Organism Type, 2021-2034 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Bacterial SCP Hydrolysates
    • 5.2.1 Methanotrophs (e.g., Methylococcus capsulatus)
    • 5.2.2 Hydrogen-Oxidizing Bacteria (e.g., Cupriavidus necator)
    • 5.2.3 Autotrophic Bacteria (e.g., Clostridium autoethanogenum)
    • 5.2.4 Other Bacteria (Bacillus, Lactobacillus, Purple Non-Sulfur)
  • 5.3 Yeast SCP Hydrolysates
    • 5.3.1 Conventional Yeasts (Saccharomyces cerevisiae, Candida utilis)
    • 5.3.2 Methylotrophic Yeasts (Pichia pastoris, Yarrowia lipolytica)
    • 5.3.3 Other Yeasts (Kluyveromyces, Rhodotorula)
  • 5.4 Fungal SCP Hydrolysates
    • 5.4.1 Filamentous Fungi (Fusarium, Aspergillus, Rhizopus)
    • 5.4.2 Other Fungi (Neurospora, Trichoderma)
  • 5.5 Microalgae & Cyanobacteria SCP Hydrolysates
    • 5.5.1 Cyanobacteria (Spirulina species)
    • 5.5.2 Green Microalgae (Chlorella, Scenedesmus)
    • 5.5.3 Other Microalgae (Nannochloropsis, Euglena)
  • 5.6 Others

Chapter 6 Market Estimates and Forecast, By Production Substrate / Feedstock, 2021-2034 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Gas-Based Substrates
    • 6.2.1 Methane, Methanol, CO2, H2
    • 6.2.2 Industrial off-gas, Biogas
  • 6.3 Carbohydrate-Based Substrates
    • 6.3.1 Molasses, Glucose, Starch Hydrolysates
    • 6.3.2 Food Processing Waste (whey, peels, brewery waste)
  • 6.4 Lignocellulosic Biomass & Agricultural Waste
    • 6.4.1 Straw, Bagasse, Wood Residues
    • 6.4.2 Spent Sulphite Liquor
  • 6.5 Animal & Industrial Byproducts
    • 6.5.1 Fish/Poultry Waste, Manure
    • 6.5.2 Crude Glycerol, Municipal Wastewater
  • 6.6 Others

Chapter 7 Market Estimates and Forecast, By Application, 2021-2034 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Animal Nutrition
    • 7.2.1 Aquafeed (fish, shrimp)
    • 7.2.2 Livestock Feed (poultry, swine, ruminants)
    • 7.2.3 Pet Food (dogs, cats)
  • 7.3 Human Food & Nutraceuticals
    • 7.3.1 Protein Supplements (sports, clinical, elderly)
    • 7.3.2 Functional Foods (beverages, bars, snacks)
    • 7.3.3 Meat & Dairy Alternatives
  • 7.4 Pharmaceutical/Nutraceutical Applications
    • 7.4.1 Bioactive Peptides (antioxidant, antihypertensive)
    • 7.4.2 Immune & Metabolic Health
  • 7.5 Cosmetic & Industrial Uses
    • 7.5.1 Skin & Hair Care Bioactives
    • 7.5.2 Bioplastic Fermentation, Culture Media
  • 7.6 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Million) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Calysta
  • 9.2 Unibio
  • 9.3 Solar Foods
  • 9.4 KnipBio
  • 9.5 Quorn Foods
  • 9.6 Arbiom
  • 9.7 Corbion
  • 9.8 DSM-Firmenich
  • 9.9 Novozymes (Now part of Novonesis)
  • 9.10 Angel Yeast
  • 9.11 Lesaffre
  • 9.12 Alltech
  • 9.13 Nutreco
  • 9.14 AlgaeCytes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!